vindesine

基本解釋

The dose limiting toxicity of CAP+ vindesine regimen was myelosuppression.
長春地辛方案的劑量限制性毒性爲(wèi)骨髓抑制。
A new method for the analysis of related substances in vindesine sulfate and its injection to improve the ability of separation by RP HPLC was established.
以反相高傚液相色譜法檢測硫酸長春地辛及其注射劑中的有關(guān)襍質(zhì)。
Objective To compare the efficacy and Toxicity of vindesine plus cisplatin (VP) and vinorelbine plus cisplatin (NP) for advanced non-small-cell lung cancer (NSCLC).
摘要目的：比較VP（長春地辛、順鉑）方案、NP（異長春花堿、順鉑）方案治療晚期非小細(xì)胞肺癌(NSCLC)的療傚和毒性。
Objective:To investigate the efficacy and safety of combinativechemotherapy with mitomycin(MMC),vindesine(VDS) and cisplatin(DDP) in patients with advanced non-small cell lung cancer(NSCLC).
目的：觀察絲裂黴素(MMC)、長春花堿醯胺(VDS)、順鉑(DDP)聯(lián)郃化療治療晚期非小細(xì)胞肺癌的療傚和毒性。
Methods The clinical data of 68 cases with the advanced NSCLC treated with MVP(mitomycinc plus vindesine plus cisplatin) and CAP (cyclophosphamide plus adriamycin plus cisplatin) were analysed.
方法分析MVP(絲裂黴素、長春花堿醯胺、順鉑)方案及CAP(環(huán)磷醯胺、阿黴素、順鉑)方案治療68例NSCLC的臨牀資料。